Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability

OBJECTIVE: To evaluate changes from baseline in patient-reported outcomes for measures of functioning and disability among patients with migraine treated with galcanezumab or placebo. METHODS: Patients with episodic migraine (4–14 monthly migraine headache days) were treated with either galcanezumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Ford, Janet H., Ayer, David W., Zhang, Qi, Carter, Jeffrey N., Leroux, Elizabeth, Skljarevski, Vladimir, Aurora, Sheena K., Tockhorn-Heidenreich, Antje, Lipton, Richard B.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693431/
https://ncbi.nlm.nih.gov/pubmed/31270220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados